Drug application
UNIPEN (NAFCILLIN SODIUM)
Drugs@FDA ANDA 062717 · WYETH AYERST
Key facts
| Drug name | UNIPEN |
|---|---|
| Active ingredients | NAFCILLIN SODIUM |
| Application type | ANDA |
| Application number | 062717 |
| Company | WYETH AYERST |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.